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CObjectives: To estimate and compare EuroQol instrument (EQ-5D)
health states’ values for pneumoccocal and human papillomavirus
(HPV) diseases in Argentina, Chile, and the United Kingdom.
Methods: Twelve vignettes were designed, pilot-tested, and adminis-
tered to a convenience sample in a cross-sectional design to elicit descrip-
tive EQ-5D state data. Country-specific EQ-5D time-trade-off-based
weights were used to map these descriptive health states into local coun-
try preference weights. Descriptive analysis is reported and intercountry
differences for each condition were compared using repeated measures
analysis of variance. Results: Seventy-three subjects completed the sur-
vey. Pneumococcal disease-related health states mean values ranged
from 0.331 (sepsis, Chile) to 0.727 (auditive sequelae, Argentina). HPV-
elated conditions ranged from 0.152 (cervical cancer, United Kingdom) to
.848 (cervical intraepithelial neoplasia 1, Argentina). Chile had consis-
ently the lowest mean values in pneumococcal states and in one HPV
tate, whereas those of the United Kingdom were the lowest in most HPV O
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doi:10.1016/j.jval.2011.05.007tates. Argentina had the highest mean values in both diseases. Differ-
nces in country-specific values for each health state were statistically
P  0.001) significant except for six health states in which differences
etween Chilean and United Kingdom weights were nonsignificant.
onclusions: Utility values for most conditions differed statistically rel-
vantly among analyzed countries, even though the same health states=
escriptive set was valued for each. These results reflect the difference in
ocial weights among different countries, which could be attributed to
ither different population values or valuation study methodologies. They
tress the importance of using local preference weights for context-spe-
ific decision making.
eywords: Great Britain, Latin America, quality-adjusted life years,
uestionnaires.
opyright © 2011, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
The measurement of health benefits is a critical activity associated
with all aspects of the planning and delivery of health care, but the
choice of unit of measure is not uniformly acknowledged. To help
to guide health care-wide resource allocation decisions, it needs to
be based on a generic system so that gains/losses can be compared
across the widest possible range of interventions [1].
Quality-adjusted life years (QALYs) are a unit of measure which
is made up of the product of quality of life and quantity of life. A
QALY refers to 1 year of life in complete health. Health status, or
quality of life, is measured on a scale in which full health has a
value of 1.0 and dead has a value of zero [2–5]. QALYs led to much
applied work based on cost-utility analysis, and approaches to
prioritization based on incremental cost-per-QALY figures, both in
upper- and lower-and-middle income countries [6].
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1098-3015/$36.00 – see front matter Copyright © 2011, Internation
Published by Elsevier Inc.QALY weights are computed either by directly eliciting subjects
preferences through direct methods (standard gamble, time-trade
off, visual analog scale) or through a two-step approach: The first one
involves classifying the health status with a preference-based, ge-
neric health-related quality of life measurement instrument; and the
second is to translate this health state to the value that the general
reference population have assigned to it in a previous valuation
study. The EuroQol instrument (EQ-5D) is probably the most widely
used standardized instrument for use as a measure of health out-
come in economic evaluations [7]. Its descriptive system classifies a
health state by a three-level Likert-type scale on five dimensions:
mobility, self-care, usual activities, pain/discomfort, and anxiety/de-
pression. The scales range from the best level (no limitations 1) to
he worst level (severe limitations  3) and thus describe health
tates in a five-digit number. In addition, it has a visual analog scale
tem where the health state is valued in a single 0 to 100 scale.
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S61V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) S 6 0 – S 6 4It has been shown that self-reported EQ-5D descriptive health
status differ considerably between countries before weighting
them through quality-of-life weighting methodologies [8]. One
concern relates to the reported differences of preference weights
for the same states from different countries [9–19] Preference/util-
ities and preference weights studies are really scarce in the Latin
American region, even though they are essential for locally rele-
vant decision making. Local utilities are not generally used in our
region, and this could be due not only to the fact that these values
are not widely available, but also that they may seem to be trans-
ferable from utility weights from developed countries [20].
The objectives of our study were to estimate and compare
EQ-5D health states’ preference values for pneumococcal and
human papillomavirus (HPV) diseases in three different coun-
tries (Argentina, Chile, and the United Kingdom), using the
same health states’ descriptive mix in the three countries. This
work was part of a larger project in which we needed to obtain
utility values for the selected health states as inputs for two
vaccination cost-effectiveness models to be applied in different
countries. Although this study was a substudy of a larger proj-
ect, and due to the scarce research in this area in Latin America,
we think that it makes a relevant regional contribution. More-
over, the conditions reported highly contribute to the burden of
disease in Latin America [21,22]. This was the rationale behind
the selection of the health states.
Methods
Descriptive data regarding the different disease-related
EQ-5D health states
To obtain descriptive data regarding the different health states
defined in the economic models, 12 health state vignettes (eight
for pneumococcal diseases and four for HPV diseases) were de-
signed, pilot-tested, and administered to a convenience sample of
subjects in Argentina. The survey was confidential and anony-
mous. After describing each of the health states with a half-page
vignette, they proceeded to complete one EQ-5D questionnaire for
each. To evaluate and control sequence or order effects, three sets
of questionnaires in which the health states were ordered in dif-
ferent ways were used and randomly administered to each third of
the sample. Both as a primer and for use as descriptive data, the
first health state for which it was asked to complete the EQ-5D
questionnaire was, in all cases, their health status the day of the
survey. Finally, some demographic descriptive data of the respon-
dents was gathered.
Analysis of questionnaire data and deriving of local
preference weights
The description of each health state consisted of an EQ-5D five-
digit number, as described above. On the other hand, time trade-
off-derived local weights for each of these health states for Argen-
tinean [9], Chilean (Víctor Zárate, University of York, personal
ommunication), and English populations [23] were available. By
pairing the five-digit number of each health state with its corre-
spondent local weight, utility values for the 12 health states could
be obtained for each and all respondents.
An initial descriptive analysis of the sample is presented, as
is a descriptive report of the health states values for each coun-
try. To illustrate similarities and differences in country-specific
values, the relationship between the Argentine, the Chilean,
and the English values was graphically shown and assessed by
analysis of variance repeated measures test. We examined the
statistical significance of the differences in country-specific val-
ues for each health state. Furthermore, for the cases where a
significant analysis of variance result was found, showing thatnot all countries were similar, we run paired t tests with a Bon-
ferroni-corrected alpha for multiple comparisons [24]. All sta-
tistical analyses were conducted using Stata/SE 8.0 (Stata Corp.,
College Station, TX).
Results
Between July and August 2009, 73 subjects completed the survey.
Study sample characteristics are shown in Table 1 (available in
Supplemental Materials found at: doi:10.1016/j.jval.2011.05.007).
Fifty-three percent of the respondents were women. Mean age
was 31 years (range 22–58) and mean self-reported health status
measured by EQ-5D’s visual analog scale was 86 out of 100.
Utility values for the health states of the HPV vaccination
model, obtained by pairing the five-digit number of each health
state with its correspondent local weight, are shown in Table 2 and
in Figure 1 (available in Supplemental Material found at: doi:
10.1016/j.jval.2011.05.007); whereas utility values for the health
states of the pneumococcal vaccination model, obtained in the
same way, are shown in Table 3, Figure 2, and Figure 3 (available in
upplemental Material found at: doi:10.1016/j.jval.2011.05.007).
ecause all values had an asymmetric distribution, we present
oth mean/confidence interval and median/interquartile range. In
ddition, in Table 4 (available in Supplemental Material found at:
oi:10.1016/j.jval.2011.05.007) we show the visual analog scale
ummary values of each of the health states. For pneumococcal
isease-related health states, means utility values ranged from
0.331 (sepsis, Chile) to 0.727 (auditive sequelae, Argentina). Re-
arding HPV-related conditions, they ranged from 0.152 (cervical
ancer, United Kingdom) to 0.848 (cervical intraepithelial neopla-
ia 1, Argentina). Chile had consistently the lowest coefficients in
neumococcal states and in one HPV state, whereas those of the
nited Kingdom were the lowest in most HPV states. Argentina
ad the highest coefficients in both disease groups. Mean differ-
nces between countries in pneumococcal health states were
.256 (Argentina-Chile), 0.207 (Argentina-UK), and 0.048 (Chile-
K); and those for HPV were 0.117 (Argentina-Chile), 0.133 (Argen-
ina-UK), and 0.017 (Chile-UK).
We found that the differences in country-specific values for
ach health state were statistically significant, and many of them
f an important magnitude, except for six health states (cervical
ntraepithelial neoplasia 1, cervical intraepithelial neoplasia 2 and
, cured cancer, meningitis, acute otitis media, and acute otitis
edia with myringotomy) in which differences between Chilean
nd English weights were nonsignificant. Argentinean weights re-
ulted significantly different and higher for all the conditions.
Discussion
Although it is not uncommon to assume that utility values to be
used in economic evaluations are usually transferable from place
to place, and many studies use for QALY calculations weights from
other settings, there is growing evidence that utilities can be sig-
nificantly and sometimes meaningfully different between settings
[9–19]. In our study we found that utility coefficients for each con-
dition differed significantly between the three analyzed countries
even considering that the same health states’ mix was valued in
all three countries. This is why, even though our sample was a
convenience sample, the fact that a health state can be descrip-
tively different between countries (i.e., a typical pneumonia could
be more severe), this could not account for the differences among
countries’ utility values. Our study is a practical exercise that
shows that in a real-life scenario and using the same set of health
states for each disease state, the difference in country valuations
introduce significant differences in results. This stress the impor-
tance of using local and not international weights in context-spe-
S62 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) S 6 0 – S 6 4cific decision-making processes such as cost-effectiveness analy-
ses and economic evaluations.
These differences we found reflect how systematic differences
in social preference weights between countries can lead to differ-
Fig. 1 – Box plots representing EQ-5D translated coefficients
vaccination model. Central horizontal line of each box: med
whiskers: upper (third quartile plus 1.5* interquartile range)
adjacent values; outside dots: outliers.
Fig. 2 – Box plots representing EQ-5D translated coefficients
vaccination model. Central horizontal line of each box: med
whiskers: upper (third quartile plus 1.5 · interquartile range
adjacent values; outside dots: outliers.ent results in difference settings, and eventually to potentially
different conclusions about effectiveness and cost-effectiveness
of different alternative strategies. The reasons for the differences
in the social value weightings in each country might be explained
ealth states included in the human papillomavirus
upper hinge: 75th percentile; lowerhinge: 25th percentile;
lower (first quartile minus 1.5* interquartile range)
our health states included in the pneumococcal
upper hinge: 75th percentile; lower hinge: 25th percentile;
lower (first quartile minus 1.5 · interquartile range)for h
ian;
andfor f
ian;
) and
S63V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) S 6 0 – S 6 4not only by the fact that they have different population character-
istics and values, but they can also be at least partially explained
by variations in the valuation protocol and method used for each
country. Although all of the local valuation studies were done with
the time-trade-off method, slightly different analysis procedures
and different sampling methods were used to allow the valuations
of all EQ-5D states to be interpolated from direct valuations, given
that it is virtually impossible to generate direct valuations for all of
the 243 possible EQ-5D health states. Chile and United Kingdom
valuation studies used probabilistic sampling, whereas the Argen-
tinean one used quota sampling. Secular trends in social prefer-
ences might also have some relevance. The United Kingdom val-
uation study was undertaken in 1993 [23], and the Chilean one 15
years later (Víctor Zárate, University of York, personal communi-
cation).
Although studies exist that compared different valuation
methods for similar health states and populations [25,26], there
are fewer studies that attempted to compare potential differ-
ences in local utilities in a given set of identical mix of health
states in different jurisdictions. As an example in our region,
Augustovski et al. [9] published a study in 2009 where they de-
veloped a set of EQ-5D health states’ values for the Argentine
general population and compared it with published values for
the United States, finding meaningful and significant differ-
ences between them. Nevertheless, this study was based on all
EQ-5D set of states and it was not related to any particular dis-
ease [9]. König et al. [8] published in 2009 a brief report where
they compared general population health status measured by
the EQ-5D in six European countries [8]. Even after adjusting for
sociodemographic variables and with representative samples,
self-reported EQ-5D health status differed considerably be-
tween countries, calling for caution when making international
comparisons of disease burden and health care effectiveness
and potential cost-effectiveness of different interventions.
Jürges [27] decomposed in 2007 cross-national differences in
Fig. 3 – Box plots representing EQ-5D translated coefficients
vaccination model. Central horizontal line of each box: med
whiskers: upper (third quartile plus 1.5 · interquartile range
adjacent values; outside dots: outliers.self-reported general health into parts explained by differencesin ’true’ health, measured by diagnosed conditions and mea-
surements, and parts explained by cross-cultural differences in
response styles, and concluded that failing to account for dif-
ferences in reporting styles may yield misleading results. There
are studies that reported that the use of anchoring vignettes
successfully improved the comparability of self reported mea-
sures [28]. Newer studies also underline the problems of using
value sets to weight profile data as EQ-5D derived health states
and that caution should be taken when choosing a summary
measure [29,30].
It would have been interesting to recruit different samples of
subjects in Argentina, Chile, and the United Kingdom to evaluate if
the same vignettes produced different responses regarding to
which EQ-5D states they correspond, or even to make locally spe-
cific vignettes to reflect potential differences between disease
states (i.e., ambulatory pneumonia) in three countries. Neverthe-
less, this was out of the scope and resources of our work and is an
issue that could be addressed in the future.
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